SCHEMBL30951395

SCHEMBL30951395

COc1cc(C(F)(F)F)cc(C)c1-c1cc2ccc(Cl)cc2nn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AGPAT2 O15120 1/20 0.35
▸ PDE2A O00408 4/20 0.35
▸ PDE10A Q9Y233 3/20 0.35
▸ PDE6D O43924 2/20 0.35
▸ PDE6A P16499 2/20 0.35
▸ PDE6G P18545 2/20 0.35
▸ PDE6B P35913 2/20 0.35
▸ PDE6C P51160 2/20 0.35
▸ PDE6H Q13956 2/20 0.35
▸ IDO1 P14902 1/20 0.34
▸ TDO2 P48775 1/20 0.34
▸ CTSA P10619 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ RAF1 P04049 1/20 0.34
▸ CASR P41180 1/20 0.34
▸ TP53 P04637 2/20 0.33
▸ IL1B P01584 1/20 0.33
▸ AR P10275 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30951380 0.81 HTR7 (0.40) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL30951394 0.81 HTR7 (0.40) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL24695405 0.69 ALOX5AP (0.40) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL30994247 0.66 IL1B (0.35) IL1B
SCHEMBL31553142 0.66 PIK3CD (0.35) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL31553141 0.66 PDE2A (0.35) PDE2APDE10APDE6DPDE6APDE6G
SCHEMBL17585457 0.66 LRRK2 (0.43) IDO1TDO2LRRK2
SCHEMBL27110496 0.65 PDE4B (0.50) PDE2ALMNATP53
SCHEMBL30994253 0.65 IL1B (0.43) IL1B
SCHEMBL12068383 0.64 KDM4E (0.50) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024094150-A1 NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2024-05-10 — — WO disclosed
Send feedback